Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study
Pratishtha Chatterjee, Wei LF Lim, Guanghou Shui, Veer B Gupta, Ian James, Anne M Fagan, Chengjie Xiong, Hamid R Sohrabi, Kevin Taddei, Belinda M Brown, Tammie Benzinger, Colin Masters, Stuart G Snowden, Marcus R Wenk, Randall J Bateman, John C Morris, Ralph N Martins
Journal of Alzheimer's Disease | IOS PRESS | Published : 2016
Awarded by NIH grant for the Dominantly Inherited Alzheimer Network study
This study was funded by the NIH grant for the Dominantly Inherited Alzheimer Network study (Grant number: U19 AG032438; JCM, PI). We thank the participants and their families for their participation and cooperation, and the DIAN research and support staff at McCusker Alzheimer Research foundation (MARF), the Mental Health Research Institute (MHRI) and Washington University for their contributions to this study. We thank the staff of the DIAN Administration, Clinical, Biomarker, Genetics and Imaging cores for their contributions. We also especially thank Dr. Krista Moulder and Mr. Scot Fague for providing us with the supporting data from the master DIAN database. PCwas being funded by the Scholarship for International Research Fees (SIRF), the University International Stipend (UIS) from the University of Western Australia and the CRC for Mental Health, Australia, while carrying out the study described in this manuscript. The Western Australian State Government of Commerce had contributed funding towards the 4000 QTRAP mass spectrometer (AB Sciex) workstation employed in this study.This study was funded by the NIH grant for the Dominantly Inherited Alzheimer Network study (Grant number: U19 AG032438; JCM, PI).